Benralizumab for treating severe eosinophilic asthma

Technology appraisal guidance
Reference number: TA565
Published: 06 March 2019
Last updated: 03 September 2019

Evidence

Supporting evidence

Evaluation report
Appraisal consultation 1 committee papers (PDF 23.72 MB)

Published:

06 March 2019
Appraisal consultation 2 committee papers (PDF 2.73 MB)

Published:

06 March 2019
Final appraisal determination committee papers (PDF 3.58 MB)

Published:

06 March 2019